MYND Life Sciences Inc (QB) (MYNDF)
USOTC
News
Market Data
Register for streaming realtime charts, analysis tools, and prices.
The current MYNDF market cap is 597.71k. The company's latest EPS is CAD -0.0317 and P/E is -0.32.
| Year End October 30 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 |
| Operating Income | -15k | -3.39M | -1.95M | -1.18M |
| Net Income | -25k | -4.37M | -3.57M | -1.52M |
| Year End October 30 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Total Assets | 170k | 2.67M | 654k | 797k |
| Total Liabilities | 197k | 2.74M | 4.19M | 5.77M |
| Total Equity | -27k | -68k | -3.53M | -4.98M |
| Year End October 30 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Operating | N/A | -2.98M | -1.82M | -198k |
| Investing | N/A | 2.13M | -81k | 198k |
| Financing | N/A | 2.75M | N/A | N/A |
| Market Cap | 597.71k |
| Price to Earnings Ratio | -0.32 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0 |
| Price to Book Ratio | -0.1 |
| Dividend Yield | - |
| Shares Outstanding | 47.82M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | -37.50% |
| 52 Week High | 0.0312 |
| 52 Week Low | 0.0125 |
| Spread (Intraday) | 0.03 (72.22%) |
| Company Name | MYND Life Sciences Inc (QB) |
| Address |
700 9 avenue, sw, #3000 vancouver, british columbia T2P 3V4 |
| Website | https://www.myndsciences.com |
| Industry | coml physical, biologcl resh (8731) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
